(4aR,5aR,7aR,8R,12aR,14aR)-4'-Hydroxy-1,1,5',7a,8,12a-hexamethyl-1,3,4,6,7,7a,7b,8,9,11a,12,12a,14,14a-tetradecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabi cyclo[3.1.0]hexan]-2-yl beta-D-xylopyranoside(CAS: 27994-11-2)
![(4aR,5aR,7aR,8R,12aR,14aR)-4'-Hydroxy-1,1,5',7a,8,12a-hexamethyl-1,3,4,6,7,7a,7b,8,9,11a,12,12a,14,14a-tetradecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabi
cyclo[3.1.0]hexan]-2-yl beta-D-xylopyranoside (4aR,5aR,7aR,8R,12aR,14aR)-4'-Hydroxy-1,1,5',7a,8,12a-hexamethyl-1,3,4,6,7,7a,7b,8,9,11a,12,12a,14,14a-tetradecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabi
cyclo[3.1.0]hexan]-2-yl beta-D-xylopyranoside](https://cnstatic.chemtradehub.com/structs/279/27994-11-2-f838.webp)
CAS号
相关产品
其他供应商提供的 (4aR,5aR,7aR,8R,12aR,14aR)-4'-Hydroxy-1,1,5',7a,8,12a-hexamethyl-1,3,4,6,7,7a,7b,8,9,11a,12,12a,14,14a-tetradecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabi cyclo[3.1.0]hexan]-2-yl beta-D-xylopyranoside
基本信息
分子式
C35H52O9
分子量
616.79 g/mol
物理状态
Powder
化学标识符
SMILES
CC1CC2C(OC3(C1C4(CCC56CC57CCC(C(C7CCC6C4(C3O)C)(C)C)OC8C(C(C(CO8)O)O)O)C)O2)C(C)(C)O
InChIKey
GQLUAQZLAZUHEL-NKMZKCBCSA-N
数据库引用
MDL号
MFCD04039818
常见问题
升麻醇-3-O-β-D-吡喃木糖苷(CAS号:27994-11-2)应遵循国际化学品安全标准,包括GHS(全球化学品统一分类和标签制度)分类、REACH(欧盟化学品注册、评估、授权和限制)法规以及FDA(美国食品药品监督管理局)和EPA(美国环境保护局)的相关规定。具体分类需根据其物理化学性质确定。
升麻醇-3-O-β-D-吡喃木糖苷通常没有直接的化学替代品,但在某些情况下,可以考虑使用其同分异构体或其他具有类似生物活性的衍生物作为替代。研究中常需根据目标化合物的特性和用途来选择合适的替代品。
升麻醇-3-O-β-D-吡喃木糖苷的研究主要集中在其生物活性和潜在药物用途上。市场趋势显示,随着天然产物和药物化学领域的深入研究,该化合物的开发和应用将有持续增长。未来的研究可能集中在其药理学特性、合成方法优化以及临床应用方面。
处理含有升麻醇-3-O-β-D-吡喃木糖苷的废料时,首先应收集并分类,确保废料的无害化处理。建议采用环保方法如焚烧或交由专业机构处理。处理过程中需严格遵守相关环保法规,确保不会对环境造成污染。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序

![N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide](https://cnstatic.chemtradehub.com/structs/391/391210-10-9-8427.webp)







![N~5~-(6-Aminohexyl)-N~7~-benzyl-3-isopropylpyrazolo[1,5-a]pyrimidine-5,7-diamine](https://cnstatic.chemtradehub.com/structs/109/1092443-52-1-11f8.webp)
![(4aR,5aR,7aR,8R,12aR,14aR)-4'-Hydroxy-1,1,5',7a,8,12a-hexamethyl-1,3,4,6,7,7a,7b,8,9,11a,12,12a,14,14a-tetradecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabi
cyclo[3.1.0]hexan]-2-yl beta-D-xylopyranoside — 赫澎(上海)生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ceccf22b2de6e8e95a5e0f/67ceccf22b2de6e8e95a5e0f-logo.webp)
![(4aR,5aR,7aR,8R,12aR,14aR)-4'-Hydroxy-1,1,5',7a,8,12a-hexamethyl-1,3,4,6,7,7a,7b,8,9,11a,12,12a,14,14a-tetradecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabi
cyclo[3.1.0]hexan]-2-yl beta-D-xylopyranoside — 陕西天多利生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ced4ec2b2de6e8e95a713f/67ced4ec2b2de6e8e95a713f-logo.webp)
![(4aR,5aR,7aR,8R,12aR,14aR)-4'-Hydroxy-1,1,5',7a,8,12a-hexamethyl-1,3,4,6,7,7a,7b,8,9,11a,12,12a,14,14a-tetradecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabi
cyclo[3.1.0]hexan]-2-yl beta-D-xylopyranoside — 云南西力生物技术股份有限公司](https://cnstatic.chemtradehub.com/suppliers/67cecac62b2de6e8e95a5839/67cecac62b2de6e8e95a5839-logo.webp)
![(4aR,5aR,7aR,8R,12aR,14aR)-4'-Hydroxy-1,1,5',7a,8,12a-hexamethyl-1,3,4,6,7,7a,7b,8,9,11a,12,12a,14,14a-tetradecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabi
cyclo[3.1.0]hexan]-2-yl beta-D-xylopyranoside — 上海安谱实验科技股份有限公司](https://cnstatic.chemtradehub.com/suppliers/67cdcfdf57537e5c8069ad2d/67cdcfdf57537e5c8069ad2d-logo.webp)
![(4aR,5aR,7aR,8R,12aR,14aR)-4'-Hydroxy-1,1,5',7a,8,12a-hexamethyl-1,3,4,6,7,7a,7b,8,9,11a,12,12a,14,14a-tetradecahydro-2H-spiro[cyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabi
cyclo[3.1.0]hexan]-2-yl beta-D-xylopyranoside — 北京博奥拓达科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce027457537e5c8069b12f/67ce027457537e5c8069b12f-logo.webp)